title: Current trends in managing carotid artery disease.
abstract: The management of carotid bifurcation disease continues to evolve. Carotid endarterectomy remains the gold standard for symptomatic patients, and for selected asymptomatic patients who have hemodynamically significant carotid stenosis. Medical management of the high-risk plaque has continued to improve and is complementary to carotid endarterectomy. Carotid angioplasty and stenting is presently being evaluated as a treatment option for high-risk patients. This article reviews the current understanding of disease management.
authors.affiliation: UCLA Division of Vascular Surgery, 200 Medical Plaza, Room 510-6, Box 956908, Los Angeles, CA 90095-6908, USA. kbiggs@mednet.ucla.edu
authors.forename: Kristen L
authors.initials: KL
authors.lastname: Biggs
authors.forename: Wesley S
authors.initials: WS
authors.lastname: Moore
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D017130:Angioplasty; D050197:Atherosclerosis / Q000188:drug therapy / Q000601:surgery; D002340:Carotid Artery Diseases / Q000601:surgery*; D016893:Carotid Stenosis / Q000188:drug therapy / Q000601:surgery; D016894:Endarterectomy, Carotid; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015607:Stents
chemical_list: D000319:Adrenergic beta-Antagonists; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors